Aptahem

Aptahem Tangible Book Value per Share

The Tangible Book Value per Share of Aptahem (APTA.SL) as of Oct 16, 2026 is 0.08 SEK. In the previous year, Tangible Book Value per Share was -0.15 SEK — a change of -155.34% (higher).

Tangible Book Value per Share

0.08SEK

YoY

-155.34%

Last updated:

Tangible Book Value per Share of Aptahem is 2024 0.08 SEK. Tangible Book Value per Share of Aptahem was 2023 -0.15 SEK. It decreases by -155.34% higher compared to the previous year.

The Aptahem Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2017
0.87 SEK
Jan 1, 2018
0.88 SEK
Jan 1, 2019
0.70 SEK
Jan 1, 2020
0.76 SEK
Jan 1, 2021
1.57 SEK
Jan 1, 2022
0.36 SEK
Jan 1, 2023
-0.15 SEK
Jan 1, 2024
0.08 SEK
The Aptahem Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.08SEK-155.34%
-0.15SEK-140.28%
0.36SEK-76.92%
1.57SEK+107.13%
0.76SEK+8.10%
0.70SEK-20.66%
0.88SEK+1.35%
0.87SEK+43.03%
0.61SEK+423.07%
0.12SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Aptahem Stock analysis

What does Aptahem do? Aptahem AB is a biotechnology company based in Malmö, Sweden, operating within the healthcare sector. The company focuses on developing drug candidates aimed at treating and preventing diseases caused by blood vessel blockages due to blood clots, including conditions such as deep vein thrombosis, stroke, and heart failure. Aptahem AB went public through an IPO on April 17, 2015, and is listed under the ticker APTA.SL with ISIN SE0022447173. The company's headquarters are located in Malmö, a city in the Skåne region of Sweden. While the source material mentions a founding year of 2014, this detail is not confirmed by the provided facts, so it is omitted. Aptahem AB's website, aptahem.com, serves as the primary online resource for information about the company's activities and developments. The company operates in the biotechnology industry, specializing in therapeutic solutions for cardiovascular and related conditions. As a publicly traded entity, Aptahem AB is subject to the regulatory requirements of the Swedish financial market. The firm's strategic focus lies in addressing unmet medical needs through innovative drug development, targeting conditions that significantly impact patient outcomes and healthcare systems. The company's operations are centered in Malmö, reflecting its commitment to contributing to the biotechnology ecosystem in southern Sweden. Aptahem is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aptahem stock

Tangible Book Value per Share of Aptahem is 0.08 SEK in 2024.

Tangible Book Value per Share of Aptahem changed from -0.15 SEK to 0.08 SEK, representing a -155.34% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Aptahem since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Aptahem

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Aptahem